From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2022 Jun 28

PMID 35763804

Authors

Thomas H Thatcher

Marc Peters-Golden

Affiliations

Soon will be listed here.

Citing Articles

The role of potential oxidative biomarkers in the prognosis of intracerebral hemorrhage and the exploration antioxidants as possible preventive and treatment options.

Yao J, Dai X, Yv X, Zheng L, Zheng J, Kuang B Front Mol Biosci. 2025; 12:1541230.

PMID: 39967652 PMC: 11832355. DOI: 10.3389/fmolb.2025.1541230.

Pathogenesis and Therapy of Hermansky-Pudlak Syndrome (HPS)-Associated Pulmonary Fibrosis.

Hu X, Wei Z, Wu Y, Zhao M, Zhou L, Lin Q Int J Mol Sci. 2024; 25(20).

PMID: 39457053 PMC: 11508683. DOI: 10.3390/ijms252011270.

The Role of Oxidative Stress and Inflammatory Parameters in Heart Failure.

Wrobel-Nowicka K, Wojciechowska C, Jachec W, Zalewska M, Romuk E Medicina (Kaunas). 2024; 60(5).

PMID: 38792942 PMC: 11123446. DOI: 10.3390/medicina60050760.

References

Arezzini B, Vecchio D, Signorini C, Stringa B, Gardi C . F-isoprostanes can mediate bleomycin-induced lung fibrosis. Free Radic Biol Med. 2017; 115:1-9. DOI: 10.1016/j.freeradbiomed.2017.11.007. View

Sanak M, Gielicz A, Nagraba K, Kaszuba M, Kumik J, Szczeklik A . Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects. J Chromatogr B Analyt Technol Biomed Life Sci. 2010; 878(21):1796-800. DOI: 10.1016/j.jchromb.2010.05.012. View

Rosenfeld L, Grover G, Stier Jr C . Ifetroban sodium: an effective TxA2/PGH2 receptor antagonist. Cardiovasc Drug Rev. 2001; 19(2):97-115. DOI: 10.1111/j.1527-3466.2001.tb00058.x. View

Malli F, Bardaka F, Tsilioni I, Karetsi E, Gourgoulianis K, Daniil Z . 8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis. Food Chem Toxicol. 2013; 61:160-3. DOI: 10.1016/j.fct.2013.05.016. View

Chebbo M, Duez C, Alessi M, Chanez P, Gras D . Platelets: a potential role in chronic respiratory diseases?. Eur Respir Rev. 2021; 30(161). PMC: 9488457. DOI: 10.1183/16000617.0062-2021. View

Ting H, Khasawneh F . Platelet function and Isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family?. J Biomed Sci. 2010; 17(1):24. PMC: 2854111. DOI: 10.1186/1423-0127-17-24. View

Khasawneh F, Huang J, Mir F, Srinivasan S, Tiruppathi C, Le Breton G . Characterization of isoprostane signaling: evidence for a unique coordination profile of 8-iso-PGF(2alpha) with the thromboxane A(2) receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets. Biochem Pharmacol. 2008; 75(12):2301-15. PMC: 3710659. DOI: 10.1016/j.bcp.2008.03.014. View

Carrington R, Jordan S, Wong Y, Pitchford S, Page C . A novel murine model of pulmonary fibrosis: the role of platelets in chronic changes induced by bleomycin. J Pharmacol Toxicol Methods. 2021; 109:107057. DOI: 10.1016/j.vascn.2021.107057. View

Dempsey E, Cool C, Littler C . Lung disease and PKCs. Pharmacol Res. 2007; 55(6):545-59. DOI: 10.1016/j.phrs.2007.04.010. View

10.

Suzuki T, Kropski J, Chen J, Carrier E, Chen X, Sherrill T . Thromboxane-Prostanoid Receptor Signaling Drives Persistent Fibroblast Activation in Pulmonary Fibrosis. Am J Respir Crit Care Med. 2022; 206(5):596-607. PMC: 9716913. DOI: 10.1164/rccm.202106-1503OC. View

11.

Smyth E . Thromboxane and the thromboxane receptor in cardiovascular disease. Clin Lipidol. 2010; 5(2):209-219. PMC: 2882156. DOI: 10.2217/clp.10.11. View

12.

Rackow A, Nagel D, McCarthy C, Judge J, Lacy S, Freeberg M . The self-fulfilling prophecy of pulmonary fibrosis: a selective inspection of pathological signalling loops. Eur Respir J. 2020; 56(5). PMC: 7931159. DOI: 10.1183/13993003.00075-2020. View

13.

Comporti M, Signorini C, Arezzini B, Vecchio D, Monaco B, Gardi C . F2-isoprostanes are not just markers of oxidative stress. Free Radic Biol Med. 2007; 44(3):247-56. DOI: 10.1016/j.freeradbiomed.2007.10.004. View

14.

Taylor M, Lukowski J, Anderton C . Spatially Resolved Mass Spectrometry at the Single Cell: Recent Innovations in Proteomics and Metabolomics. J Am Soc Mass Spectrom. 2021; 32(4):872-894. PMC: 8033567. DOI: 10.1021/jasms.0c00439. View

15.

Cruz-Gervis R, Stecenko A, Dworski R, Lane K, Loyd J, Pierson R . Altered prostanoid production by fibroblasts cultured from the lungs of human subjects with idiopathic pulmonary fibrosis. Respir Res. 2002; 3:17. PMC: 107846. DOI: 10.1186/rr166. View

16.

Knipe R, Tager A, Liao J . The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis. Pharmacol Rev. 2014; 67(1):103-17. PMC: 4279074. DOI: 10.1124/pr.114.009381. View

17.

Chow S, Thomas P, Malouf M, Yates D . Exhaled breath condensate (EBC) biomarkers in pulmonary fibrosis. J Breath Res. 2012; 6(1):016004. DOI: 10.1088/1752-7155/6/1/016004. View

18.

Nakahata N . Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther. 2008; 118(1):18-35. DOI: 10.1016/j.pharmthera.2008.01.001. View

19.

Arai T, Hirose M, Kagawa T, Hatsuda K, Inoue Y . Platelet-derived growth factor can predict survival and acute exacerbation in patients with idiopathic pulmonary fibrosis. J Thorac Dis. 2022; 14(2):278-294. PMC: 8902107. DOI: 10.21037/jtd-21-1418. View